Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Charles River Laboratories (CRL)

Charles River Laboratories International Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:CRL
DateTimeSourceHeadlineSymbolCompany
16/05/202421:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
16/05/202400:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
16/05/202400:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202422:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202422:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202422:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202422:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202422:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202422:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202422:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202421:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
14/05/202421:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
10/05/202421:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:CRLCharles River Laboratories International Inc
10/05/202416:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
09/05/202421:20Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:CRLCharles River Laboratories International Inc
09/05/202414:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CRLCharles River Laboratories International Inc
09/05/202412:31Edgar (US Regulatory)Form 8-K - Current reportNYSE:CRLCharles River Laboratories International Inc
09/05/202412:00Business WireCharles River Laboratories Announces First-Quarter 2024 ResultsNYSE:CRLCharles River Laboratories International Inc
02/05/202413:00Business WireCharles River Launches Viral Vector Reference Materials to Streamline the Transition to GMPNYSE:CRLCharles River Laboratories International Inc
22/04/202413:00Business WireCharles River Laboratories Achieves 100% Renewable Electricity Usage GloballyNYSE:CRLCharles River Laboratories International Inc
16/04/202413:00Business WireCharles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal TestingNYSE:CRLCharles River Laboratories International Inc
12/04/202413:00Business WireCharles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference CallNYSE:CRLCharles River Laboratories International Inc
11/04/202413:00Business WireCharles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic PathologyNYSE:CRLCharles River Laboratories International Inc
09/04/202413:00Business WireCharles River Announces Rare Disease Gene Therapy Collaboration with Axovia TherapeuticsNYSE:CRLCharles River Laboratories International Inc
04/04/202413:00Business WireCharles River to Perform Plasmid Production for Ship of TheseusNYSE:CRLCharles River Laboratories International Inc
04/04/202413:00Business WireCharles River to Perform Plasmid Production for Ship of TheseusNYSE:CRLCharles River Laboratories International Inc
01/04/202413:00Business WireCharles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024NYSE:CRLCharles River Laboratories International Inc
27/03/202412:00Business WireCharles River Laboratories Publishes 2023 Corporate Citizenship ReportNYSE:CRLCharles River Laboratories International Inc
21/03/202412:00Business WireCharles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of MedicineNYSE:CRLCharles River Laboratories International Inc
 Showing the most relevant articles for your search:NYSE:CRL